NCT07372963 is a clinical trial of 18F-FAPI PET in Cancer of Unknown Primary Site, sponsored by First Affiliated Hospital of Zhejiang University.

Who is sponsoring NCT07372963?

NCT07372963 is sponsored by First Affiliated Hospital of Zhejiang University.

What drugs are being tested in NCT07372963?

Interventions in NCT07372963: 18F-FAPI PET.

What condition does NCT07372963 study?

NCT07372963 studies Cancer of Unknown Primary Site.

Is NCT07372963 still recruiting?

NCT07372963 is currently not yet recruiting. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT07372963

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

18F-FAPI PET in Cancers of Unknown Primary Site

Not yet recruiting Last updated 28 January 2026

What this trial tests

trial testing 18F-FAPI PET in Cancer of Unknown Primary Site in 120 participants. Not yet recruiting.

Timeline

1 February 2026

Primary endpoint
31 December 2027

31 December 2028

Quick facts

Lead sponsor	First Affiliated Hospital of Zhejiang University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 February 2026
Primary completion	31 December 2027
Estimated completion	31 December 2028
Sites	1 location across China

Drugs / interventions tested

18F-FAPI PET

Conditions studied

Cancer of Unknown Primary Site — all drugs for Cancer of Unknown Primary Site →

Sponsor

First Affiliated Hospital of Zhejiang University

Who can join

Adults 20 to 85, any sex, with Cancer of Unknown Primary Site. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the diagnostic efficacy, therapeutic assessment, prognostic analysis, and impact on clinical treatment decisions of 18F-FAPI PET/CT in patients with cancer of unknown primary.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 18F-FAPI PET

Trials testing the same drug.

NCT07370805 — 18F-FAPI PET in Lung Cancer · not yet recruiting

Other recruiting trials for Cancer of Unknown Primary Site

Currently open trials in the same condition.

NCT04459273 — Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers · Phase 1 · active not recruiting

Other First Affiliated Hospital of Zhejiang University trials

Trials by the same sponsor.

NCT07537192 — Inulin-Spirulina Co-intervention for Insomnia Disorder · NA · not yet recruiting
NCT07510867 — 18F-FAPI PET/CT and MRI in Gastric Cancer · not yet recruiting
NCT07589647 — Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic D · NA · recruiting
NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
NCT07468162 — Characteristic Electroencephalogram of General Anesthesia · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07372963 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Zhejiang University
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07372963.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing